They found that dieckol may improve the efficacy of platinum drugs for ovarian cancer, by enhancing cancer cell apoptosis via the ROS/Akt/NFκB pathway and reducing nephrotoxicity. This evidence concerns the gene NFKB1 and ovarian carcinoma.